Trial Profile
A study evaluating effect of finglimod on nervous conduction.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2017
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 15 May 2017 New trial record